$TENX News Article - Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) | Benzinga
https://marketwirenews.com/news-releases/tena...15826.html